BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Schizophrenia

Schizophrenia, from the Greek roots schizein and phrēn, phren- , is a psychiatric diagnosis that describes a mental illness characterized by impairments in the perception or expression of reality, most commonly manifesting as auditory hallucinations, paranoid or bizarre delusions or disorganized speech and thinking in the context of significant social or occupational dysfunction. Onset of symptoms typically occurs in young adulthood, with approximately 0.4–0.6% of the population affected. Diagnosis is based on the patient's self-reported experiences and observed behavior. No laboratory test for schizophrenia exists. (From the Wikpedia article Schizophrenia.)

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Schizophrenia:

Pubmed Logo
Behaviour problems in childhood and adolescence in psychotic offenders: an exploratory study.
Background Several studies have shown that adults who develop...
12th July, 2008
Pompe Foundation, Nijmegen, The Netherlands. Crim Behav Ment Health. 2008 Jul 10;18(3):153-165.
DOI Direct Link
A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.
RATIONALE: The development and validation of animal models of the...
12th July, 2008
Department of Psychology, University of Michigan, 530 Church Street, 4032 Psychopharmacology (Berl). 2008 Jul 10;.
DOI Direct Link
Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration.
RATIONALE: Nicotine-induced cognitive enhancement may be a factor...
12th July, 2008
Department of Psychiatry, School of Medicine, University of California, Psychopharmacology (Berl). 2008 Jul 11;.
DOI Direct Link
How Frequent is Chronic Multiyear Delusional Activity and Recovery in Schizophrenia: A 20-Year Multi-follow-up.
To determine how frequent chronic multiyear delusional activity is in...
12th July, 2008
2Department of Psychiatry, University of Illinois College of Medicine, Schizophr Bull. 2008 Jul 9;.
DOI Direct Link
Polymorphisms in human endogenous retrovirus K-18 and risk of type 2 diabetes in individuals with schizophrenia.
Type 2 diabetes is a major health problem in individuals with...
12th July, 2008
Sheppard Pratt Health System, 6501 N. Charles Street, Baltimore, MD 21285, Schizophr Res. 2008 Jul 9;.
DOI Direct Link

View more research publications.

BioNews Results for Schizophrenia:

RSS Logo
BioPortfolio Logo
TopAbstracts in Schizophrenia 07/10/2008
Doctors Guide:  Jul 11 2008 10:50PM Matching: schizophrenia
Feuerstein's Biotech-Stock Mailbag: Acadia
TheStreet.com:  Jul 12 2008 12:18AM Matching: schizophrenia
Woman's Hospital Floor Death Blamed On Blood Clots
CBS 4 Denver:  Jul 12 2008 5:14AM Matching: schizophrenia
Home genetic tests: How much do you really want to know?
The Independent:  Jul 12 2008 12:56AM Matching: schizophrenia
Allon Granted U.S. Patent for Lead Product in New Technology Platform
Bioscience World/Biotechnology Focus:  Jul 11 2008 10:45PM Matching: schizophrenia
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Schizophrenia Clinical Trials:

Clinical Trials Logo
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
Schizophrenias;   Psychoses;   Psychotic Disorders;   Schizophrenic Disorders
Efficacy and Safety of AVE1625 as a co-Treatment With Antipsychotic Therapy in Schizophrenia
Schizophrenia Intervention: Drug: AVE1625
Pregnenolone in the Management of Schizophrenia Patients
Schizophrenia Intervention: Drug: Pregnenolone
Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients
Schizophrenia Intervention: Drug: memantine HCl
Oxygen Therapy in Schizophrenia
Chronic Schizophrenia

View more trials.

Schizophrenia Patents:

USPTO Logo
US Patent No.Title
7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof
7388005 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
7388022 Polysubstituted 1,1-pyridylaminocyclopropanamine compounds
7388023 Amino acids with affinity for the .alpha.2.delta.-protein
7388024 Indeno[2,1A]indenes and isoindolo[2,1-A]indoles

View more patents.

Companies working in the area of Schizophrenia from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Clinical Insights

Clinical Insights was established in 1996 as an independent clinical trial center specializing in Phase II, III, and IV psychopharmacological research. The mission of Clinical Insights is to become...
www.clinicalinsights.com/        View full profile
Thumbshot

Eli Lilly and Company

Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer,...
www.lilly.com/        View full profile
Thumbshot

Laxdale Limited

Psychiatric and CNS diseases, including schizophrenia, bipolar disorders, depression and alzheimer's disease...
www.laxdale.co.uk/        View full profile
Thumbshot

View more Schizophrenia related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Schizophrenia scientists - we have details of around 7758 individuals working on Schizophrenia .


This page has been viewed 86 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Schizophrenia across BioPortfolio, or bestselling Schizophrenia books or recently published Schizophrenia books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional